Site- and allele-specific polycomb dysregulation in T-cell leukaemia

Nature Communications

Volumn 6, Issue , 2015, Pages

  Navarro, Jean Marc ^a,b   Touzart, Aurore ^c   Pradel, Lydie C ^a,b,k   Loosveld, Marie ^a,b,d   Koubi, Myriam ^e   Fenouil, Romain ^a,b   Le Noir, Sandrine ^c   Maqbool, Muhammad Ahmad ^a,b,l   Morgado, Ester ^a,b   Gregoire, Claude ^a,b   Jaeger, Sebastien ^a,b   Mamessier, Emilie ^a,b   Pignon, Charles ^a,b   Hacein Bey Abina, Salima ^f   Malissen, Bernard ^a,b   Gut, Marta ^g   Gut, Ivo G ^g   Dombret, Hervé ^h   MacIntyre, Elizabeth A ^c   Howe, Steven J ⁱ   Gaspar, H Bobby ⁱ   Thrasher, Adrian J ⁱ   Ifrah, Norbert ^j   Payet Bornet, Dominique ^a,b   Duprez, Estelle ^d   Andrau, Jean Christophe ^a,b,l   Asnafi, Vahid ^c   Nadel, Bertrand ^a,b   more..

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g Centro Nacional de Analisis Genomico   (Spain)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j ANGERS UNIVERSITY HOSPITAL   (France)

^k Aix Marseille university   (France)

^l INSTITUT DE GÉNÉTIQUE MOLÉCULAIRE DE MONTPELLIER   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; TRANSCRIPTION FACTOR TAL1; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; HISTONE; HOMEODOMAIN PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; POLYCOMB GROUP PROTEIN; RAG-1 PROTEIN; RAG2 PROTEIN, HUMAN; TAL1 PROTEIN, HUMAN;

ALLELE; BIOASSAY; CELL ORGANELLE; GENE EXPRESSION; GENETIC ANALYSIS; HETEROGENEITY;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CANCER SURVIVAL; CELL LINEAGE; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 1; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CONTROLLED STUDY; EPIGENETICS; ERYTHROBLAST; GENE EXPRESSION REGULATION; GENE INSERTION; GENE LOCUS; GENE SILENCING; GERM LINE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MUTAGENESIS; ONCOGENE; OUTCOME ASSESSMENT; PROMOTER REGION; T CELL LEUKEMIA; TAL1 GENE; ACETYLATION; ACUTE LYMPHOBLASTIC LEUKEMIA; GENETIC EPIGENESIS; GENETICS; JURKAT CELL LINE; METABOLISM; METHYLATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PLASMID; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

ACETYLATION; ADULT; ALLELES; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, LEUKEMIC; GENETIC LOCI; HISTONES; HOMEODOMAIN PROTEINS; HUMANS; JURKAT CELLS; METHYLATION; MOLECULAR SEQUENCE DATA; MUTAGENESIS, INSERTIONAL; NUCLEAR PROTEINS; PLASMIDS; POLYCOMB-GROUP PROTEINS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84923096527     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7094     Document Type: Article

References (44)

1. Teitell, M. A. & Pandolfi, P. P. Molecular genetics of acute lymphoblastic leukemia. Annu. Rev. Pathol. 4, 175-198 (2009).
2. Van Vlierberghe, P., Pieters, R., Beverloo, H. B. & Meijerink, J. P. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br. J. Haematol. 143, 153-168 (2008).
3. Sanda, T. et al. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22, 209-221 (2012).
4. Mouthon, M. A. et al. Expression of tal-1 and GATA-binding proteins during human hematopoiesis. Blood 81, 647-655 (1993).
5. Herblot, S., Steff, A. M., Hugo, P., Aplan, P. D. & Hoang, T. SCL and LMO1 alter thymocyte differentiation: inhibition of E2A-HEB function and pre-T alpha chain expression. Nat. Immunol. 1, 138-144 (2000).
6. Zhang, J. A., Mortazavi, A., Williams, B. A., Wold, B. J. & Rothenberg, E. V. Dynamic transformations of genome-wide epigenetic marking and transcriptional control establish T cell identity. Cell 149, 467-482 (2012).
7. Ferrando, A. A. et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. Blood 103, 1909-1911 (2004).
8. Hiom, K., Melek, M. & Gellert, M. DNA transposition by the RAG1 and RAG2 proteins: a possible source of oncogenic translocations. Cell 94, 463-470 (1998).
9. Agrawal, A., Eastman, Q. M. & Schatz, D. G. Transposition mediated by RAG1 and RAG2 and its implications for the evolution of the immune system. Nature 394, 744-751 (1998).
10. Koch, F. et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat. Struct. Mol. Biol. 18, 956-963 (2011).
11. Cuddapah, S. et al. Global analysis of the insulator binding protein CTCF in chromatin barrier regions reveals demarcation of active and repressive domains. Genome Res. 19, 24-32 (2009).
12. Cui, K. et al. Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation. Cell Stem Cell 4, 80-93 (2009).
13. Zhou, Y. et al. Chromatin looping defines expression of TAL1, its flanking genes and regulation in T-ALL. Blood 122, 4199-4209 (2013).
14. McCabe, M. T. et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 492, 108-112 (2012).
15. Cardoso, B. A. et al. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells. Leukaemia 25, 1578-1586 (2011).
16. Howe, S. J. et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118, 3143-3150 (2008).
17. Brandt, V. L. & Roth, D. B. V(D)J recombination: how to tame a transposase. Immunol. Rev. 200, 249-260 (2004).
18. Clappier, E. et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 110, 1251-1261 (2007).
19. Ntziachristos, P. et al. Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia. Nat Med. 18, 298-301 (2012).
20. Simon, C. et al. A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia. Genes Dev. (2012).
21. Zhang, J. et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481, 157-163 (2012).
22. Grossmann, V. et al. EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemia. Br. J. Haematol. 157, 387-390 (2012).
23. Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398-3406 (2012).
24. Marculescu, R., Le, T., Simon, P., Jaeger, U. & Nadel, B. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J. Exp. Med. 195, 85-98 (2002).
25. Mendes, R. D. et al. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events. Blood 124, 567-578 (2014).
26. Marculescu, R. et al. Distinct t(7;9)(q34;q32) breakpoints in healthy individuals and individuals with T-ALL. Nat. Genet. 33, 342-344 (2003).
27. Vanura, K. et al. In vivo reinsertion of excised episomes by the V(D)J recombinase: a potential threat to genomic stability. PLoS Biol. 5, e43 (2007).
28. Reddy, Y. V. R., Perkins, E. J. & Ramsden, D. A. Genomic instability due to V(D)J recombination-associated transposition. Genes Dev. 20, 1575-1582 (2006).
29. Curry, J. D. et al. Chromosomal reinsertion of broken RSS ends during T cell development. J. Exp. Med. 204, 2293-2303 (2007).
30. Messier, T. L., O'Neill, J. P., Hou, S. M., Nicklas, J. A. & Finette, B. A. In vivo transposition mediated by V(D)J recombinase in human T lymphocytes. EMBO J. 22, 1381-1388 (2003).
31. Hacein-Bey-Abina, S. et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. New Engl. J. Med. 346, 1185-1193 (2002).
32. Hacein-Bey-Abina, S. et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419 (2003).
33. Ntziachristos, P. et al. Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia. Nature 514, 513-517 (2014).
34. Bracken, A. P. & Helin, K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat. Rev. Cancer 9, 773-784 (2009).
35. Van der Meulen, J., Van Roy, N., Van Vlierberghe, P. & Speleman, F. The epigenetic landscape of T-cell acute lymphoblastic leukemia. Int. J. Biochem. Cell Biol. (2014).
36. Fenouil, R. et al. CpG islands and GC content dictate nucleosome depletion in a transcription-independent manner at mammalian promoters. Genome Res. 22, 2399-2408 (2012).
37. Roulland, S. et al. Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J. Exp. Med. 203, 2425-2431 (2006).
38. Asnafi, V. et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood 101, 2693-2703 (2003).
39. Asnafi, V. et al. Age-related phenotypic and oncogenic differences in T-acute lymphoblastic leukemias may reflect thymic atrophy. Blood (2004).
40. Bergeron, J. et al. Prognostic and oncogenic relevance of TLX1/HOX11 expression level in T-ALLs. Blood 110, 2324-2330 (2007).
41. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
42. Mochizuki-Kashio, M. et al. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. Blood 118, 6553-6561 (2011).
43. Delabesse, E. et al. TAL1 expression does not occur in the majority of T-ALL blasts. Br. J. Haematol. 102, 449-457 (1998).
44. Neiditch, M. B., Lee, G. S., Huye, L. E., Brandt, V. L. & Roth, D. B. The V(D)J recombinase efficiently cleaves and transposes signal joints. Mol. Cell 9, 871-878 (2002).